Qiagen and CytoPathfinder Combines Technologies in RNAi Screening
News May 24, 2006
Qiagen and CytoPathfinder have announced the formation of a strategic partnership between the two companies to combine their technologies in developing advanced tools for high-throughput RNAi screening.
CytoPathfinder has developed a Transfection Microarray technology (TMA) which allows high-throughput siRNA screening on a microarray chip.
Both companies have agreed to combine product knowledge and technology platforms to develop new-generation tools for high-throughput RNAi screening.
These developments have made high-throughput RNAi accessible to both pharmaceutical companies and academic researchers.
Single Gene Change in Gut Bacteria Alters Host MetabolismNews
Scientists have found that deleting a single gene in a particular strain of gut bacteria causes changes in metabolism and reduced weight gain in mice. The research provides an important step towards understanding how the microbiome – the bacteria that live in our body – affects metabolism.READ MORE
Gotta Sample 'Em All! Underwater Pokéball Captures Ocean LifeNews
A new device developed by Wyss Institute reseachers safely traps delicate sea creatures inside a folding polyhedral enclosure and lets them go without harm using a novel, origami-inspired design. The ultimate aim is to allow the sea creatures to be (gently) analyzed in high detail.READ MORE
Big Data Study Targets Genomic Dark Matter from Ocean Floor to Gut FloraNews
An international team led by computational biologist Fran Supek at IRB Barcelona develop a machine learning method to predict unknown gene functions of microbes.The system examines and compares ‘big data’ available on the metagenomes of human and environmental microbiomes.READ MORE
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019